Healthcare provider profile · identity verified

Drew T Emerson, M.D.

Family Practice · LAKEVILLE, NY · NPI 1437187655

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	493	84
Amlodipine Besylate	Amlodipine Besylate	463	104
Omeprazole	Omeprazole	371	75
Rosuvastatin Calcium	Rosuvastatin Calcium	350	92
Lisinopril	Lisinopril	347	82
Atorvastatin Calcium	Atorvastatin Calcium	281	69
Losartan Potassium	Losartan Potassium	259	62
Metoprolol Succinate	Metoprolol Succinate	258	64
Pantoprazole Sodium	Pantoprazole Sodium	213	43
Hydrochlorothiazide	Hydrochlorothiazide	212	49
Gabapentin	Gabapentin	210	47
Tamsulosin Hcl	Tamsulosin Hcl	180	41
Ezetimibe	Ezetimibe	174	43
Furosemide	Furosemide	173	38
Lovastatin	Lovastatin	171	41
Sertraline Hcl	Sertraline Hcl	170	36
Duloxetine Hcl	Duloxetine Hcl	165	27
Metformin Hcl	Metformin Hcl	163	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	25
Metoprolol Tartrate	Metoprolol Tartrate	146	34
Albuterol Sulfate Hfa	Albuterol Sulfate	137	41
Glimepiride	Glimepiride	124	28
Tramadol Hcl	Tramadol Hcl	114	27
Warfarin Sodium	Warfarin Sodium	114	13
Metformin Hcl Er	Metformin Hcl	112	29
Ozempic	Semaglutide	108	17
Alprazolam	Alprazolam	105	26
Finasteride	Finasteride	95	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	20
Baclofen	Baclofen	91	17
Oxycodone Hcl	Oxycodone Hcl	91	16
Trazodone Hcl	Trazodone Hcl	91	20
Alendronate Sodium	Alendronate Sodium	87	20
Clonazepam	Clonazepam	86	11
Escitalopram Oxalate	Escitalopram Oxalate	86	15
Fluticasone Propionate	Fluticasone Propionate	79	19
Azithromycin	Azithromycin	78	64
Zolpidem Tartrate	Zolpidem Tartrate	74	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	25
Paroxetine Hcl	Paroxetine Hcl	71	11
Celecoxib	Celecoxib	70	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	70	12
Simvastatin	Simvastatin	69	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	suppressed
Eliquis	Apixaban	68	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	suppressed
Ropinirole Hcl	Ropinirole Hcl	65	12
Famotidine	Famotidine	63	16
Chlorthalidone	Chlorthalidone	56	13
Venlafaxine Hcl Er	Venlafaxine Hcl	56	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Atenolol	Atenolol	53	12
Ibuprofen	Ibuprofen	53	17
Montelukast Sodium	Montelukast Sodium	52	11
Amitriptyline Hcl	Amitriptyline Hcl	51	11
Venlafaxine Hcl	Venlafaxine Hcl	51	suppressed
Allopurinol	Allopurinol	50	11
Acetaminophen-Codeine	Acetaminophen With Codeine	48	suppressed
Divalproex Sodium	Divalproex Sodium	47	suppressed
Lorazepam	Lorazepam	47	suppressed
Spironolactone	Spironolactone	47	12
Trulicity	Dulaglutide	47	12
Clopidogrel	Clopidogrel Bisulfate	45	suppressed
Prednisone	Prednisone	45	31
Bupropion Xl	Bupropion Hcl	43	suppressed
Potassium Chloride	Potassium Chloride	43	12
Repatha Sureclick	Evolocumab	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	14
Irbesartan	Irbesartan	40	suppressed
Sucralfate	Sucralfate	40	11
Doxycycline Hyclate	Doxycycline Hyclate	38	31
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	36	suppressed
Cholestyramine	Cholestyramine (With Sugar)	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Diazepam	Diazepam	35	11
Nystatin	Nystatin	35	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Olanzapine	Olanzapine	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	30	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	25
Torsemide	Torsemide	30	suppressed
Ketoconazole	Ketoconazole	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Amoxicillin	Amoxicillin	26	21
Naproxen	Naproxen	26	suppressed
Phenobarbital	Phenobarbital	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	19
Synthroid	Levothyroxine Sodium	25	suppressed
Invokana	Canagliflozin	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Carvedilol	Carvedilol	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Jardiance	Empagliflozin	19	suppressed
Nexletol	Bempedoic Acid	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Naloxone Hcl	Naloxone Hcl	18	17
Propranolol Hcl	Propranolol Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Naltrexone Hcl	Naltrexone Hcl	17	suppressed
Cephalexin	Cephalexin	16	13
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Pulmicort Flexhaler	Budesonide	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	14
Methocarbamol	Methocarbamol	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Metolazone	Metolazone	13	suppressed
Primidone	Primidone	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Briviact	Brivaracetam	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Colchicine	Colchicine	12	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nadolol	Nadolol	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error